Compare EMN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMN | ICLR |
|---|---|---|
| Founded | 1920 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 13.1B |
| IPO Year | 1996 | 2001 |
| Metric | EMN | ICLR |
|---|---|---|
| Price | $65.55 | $168.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $79.31 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 896.2K | 746.4K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $8,752,000,000.00 | N/A |
| Revenue This Year | $3.06 | N/A |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $26.12 | ★ $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.11 | $66.57 |
| 52 Week High | $83.47 | $203.91 |
| Indicator | EMN | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 33.04 | 51.70 |
| Support Level | $62.26 | $162.06 |
| Resistance Level | $66.10 | $183.11 |
| Average True Range (ATR) | 1.65 | 6.13 |
| MACD | -0.57 | 0.29 |
| Stochastic Oscillator | 9.60 | 55.72 |
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.